In contrast, in bladder tumor, the lack of ABO (H) antigen is a well-documented event and was associated with tumor progression and recurrent disease which are attributed to the loss of relevant GT activities due to downregulation of ABO (H) mRNA transcripts (82, 83, 84). Here, ABO is linked to neoplasm.